Loading...
XSWX
CPHN
Market cap422mUSD
Apr 09, Last price  
60.20CHF
1D
-5.94%
1Q
-26.41%
Jan 2017
50.50%
Name

CPH Chemie und Papier Holding AG

Chart & Performance

D1W1MN
No data to show
P/E
77.63
P/S
0.81
EPS
0.78
Div Yield, %
49.83%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-3.12%
Revenues
448m
-28.23%
462,561,000507,758,000593,523,000570,358,000481,674,000417,396,000520,932,000488,691,000481,850,000492,817,000420,278,000437,546,000473,123,000537,391,000524,657,000445,189,000496,693,000725,351,000623,982,000447,857,000
Net income
5m
-94.11%
44,961,00049,464,00043,379,00030,596,00035,782,000-20,010,000-17,991,0008,061,000-271,480,00010,502,000-33,122,999-7,905,00015,983,00042,293,00048,341,00046,901,000-151,559,000100,953,00078,885,0004,648,000
CFO
46m
-58.42%
84,709,00088,929,00068,881,00082,331,000182,086,00079,445,000-13,808,00040,757,00031,409,00019,819,00023,313,00021,875,00032,189,99964,290,00061,027,00054,958,00015,833,00097,628,000109,862,00045,683,000
Dividend
Jun 25, 202426 CHF/sh
Earnings
Jul 16, 2025

Profile

CPH Chemie + Papier Holding AG, together with its subsidiaries, engages in developing, manufacturing, and distributing chemicals, printing paper, and pharmaceutical packaging films. The Chemistry division develops, manufactures, and distributes a range of molecular sieves, special zeolites, chromatography gels, and deuterated solvents under the Zeochem brand. The Paper division manufactures newsprint and magazine paper products under the Perlen Papier brand; and recycles domestically recovered paper. The Packaging division provides a range of PVC monofilms and coated PVdC high-barrier films for use in the pharmaceutical industry under the Perlen Packaging brand name. It operates in Switzerland, rest of Europe, the Americas, Asia, and internationally. The company was founded in 1818 and is headquartered in Root, Switzerland.
URL
https://www.cph.ch/
IPO date
Jun 11, 2001
Employees
1,184
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
447,857
-28.23%
623,982
-13.98%
725,351
46.04%
Cost of revenue
285,547
399,314
600,141
Unusual Expense (Income)
NOPBT
162,310
224,668
125,210
NOPBT Margin
36.24%
36.01%
17.26%
Operating Taxes
7,215
12,974
(886)
Tax Rate
4.45%
5.77%
NOPAT
155,095
211,694
126,096
Net income
4,648
-94.11%
78,885
-21.86%
100,953
-166.61%
Dividends
(24,000)
(27,000)
(7,800)
Dividend yield
5.45%
5.30%
1.67%
Proceeds from repurchase of equity
(491)
(588)
10,975
BB yield
0.11%
0.12%
-2.35%
Debt
Debt current
10,986
723
98,851
Long-term debt
7,952
102
Deferred revenue
Other long-term liabilities
33,792
30,166
27,385
Net debt
(12,664)
(116,917)
(69,757)
Cash flow
Cash from operating activities
45,683
109,862
97,628
CAPEX
(22,997)
(34,646)
(33,905)
Cash from investing activities
(46,743)
(17,999)
(29,620)
Cash from financing activities
(75,520)
(125,662)
(18,988)
FCF
258,338
225,833
85,226
Balance
Cash
31,602
107,640
143,614
Long term investments
10,000
25,096
Excess cash
9,209
86,441
132,442
Stockholders' equity
209,902
436,679
399,567
Invested Capital
252,968
380,719
391,498
ROIC
48.95%
54.83%
34.66%
ROCE
61.91%
46.97%
23.64%
EV
Common stock shares outstanding
5,997
5,999
6,000
Price
73.40
-13.65%
85.00
8.97%
78.00
27.87%
Market cap
440,209
-13.66%
509,874
8.95%
467,990
27.87%
EV
427,545
392,957
399,590
EBITDA
180,534
243,870
143,839
EV/EBITDA
2.37
1.61
2.78
Interest
810
1,389
2,940
Interest/NOPBT
0.50%
0.62%
2.35%